Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.

OBJECTIVE To investigate modifiable and nonmodifiable risk factors for stroke in type 2 diabetes mellitus. PATIENTS AND METHODS A total of 3776 patients aged 25 to 65 years newly diagnosed as having type 2 diabetes mellitus without known cardiovascular or other serious disease were studied for a median of 7.9 years. An initial stepwise evaluation of risk factors was done in 2704 patients with all risk factors measured, with the final Cox model analysis being of 3776 patients who had complete data on the selected variables. RESULTS Of 3776 patients, 99 (2.6%) had a stroke. Significant risk factors for stroke in a multivariate model were age (estimated hazard ratio [95% confidence interval], 4.78 [2.56-8.92] for > or =60 vs <50 years), male sex (1.63 [1.08-2.47)] vs female), hypertension (2.47 [1.64-3.74)] vs normotension), and in 3728 patients who had electrocardiography at study entry, atrial fibrillation (8.05 [3.52-18.44] vs sinus rhythm). Obesity, lack of exercise, smoking, poor glycemic control, hyperinsulinemia, dyslipidemia, and microalbuminuria were not significantly associated with stroke in the model. CONCLUSION In patients with type 2 diabetes, aggressive antihypertensive therapy and routine anticoagulation therapy for atrial fibrillation may reduce the risk of stroke.

[1]  D. Bell,et al.  Stroke in the diabetic patient. , 1994, Diabetes care.

[2]  E. Melamed,et al.  Hypertension and Diabetes as Risk Factors in Stroke Patients , 1973, Stroke.

[3]  B. Schulte,et al.  An evaluation of risk factors for stroke in a Dutch community. , 1982, Stroke.

[4]  R. Holman,et al.  Hypertension in Diabetes Study IV. Therapeutic requirements to maintain tight blood pressure control Hypertension in Diabetes Study Group* , 1996, Diabetologia.

[5]  D. Cox.  Regression Models and Life-Tables , 1972 .

[6]  D. Lackland,et al.  Hypertension-Related Mortality and Morbidity in the Southeast , 1997, Southern medical journal.

[7]  L. Niskanen,et al.  Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. , 1996, Stroke.

[8]  L. Elveback,et al.  Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. , 1978, Advances in neurology.

[9]  L. Elveback,et al.  Transient ischemic attack and stroke in a community-based diabetic cohort. , 1983, Mayo Clinic proceedings.

[10]  B. Lindegård,et al.  Associations between brain infarction, diabetes and alcoholism: observations from the Gothenburg population cohort study , 1987, Acta neurologica Scandinavica.

[11]  J. Cutler.  Calcium-channel blockers for hypertension--uncertainty continues. , 1998, The New England journal of medicine.

[12]  K. Kupka,et al.  International classification of diseases: ninth revision. , 1978, WHO chronicle.

[13]  M. Laakso,et al.  Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. , 1996, Stroke.

[14]  R. Sacco,et al.  Risk factors and outcomes for ischemic stroke. , 1995, Neurology.

[15]  K. Asplund,et al.  Clinical characteristics in diabetic stroke patients. , 1988, Diabete & metabolisme.

[16]  W. Barker,et al.  Community surveillance of stroke in persons under 70 years old: contribution of uncontrolled hypertension. , 1983, American journal of public health.

[17]  D. Kromhout.  Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.

[18]  J. Yudkin.  Factors Influencing Threshold and Choice of Treatment for Hypertension in NIDDM: Cardiovascular Factors , 1991, Diabetes Care.

[19]  A. G. Shaper,et al.  Physical activity and stroke in British middle aged men. , 1992, BMJ.

[20]  J. Biller,et al.  Diabetes und Schlaganfall1 , 2005, Deutsche medizinische Wochenschrift.

[21]  J. Popper,et al.  Factors Related to Stroke Incidence in Hawaii Japanese Men: The Honolulu Heart Study , 1980, Stroke.

[22]  P. Kowey,et al.  Atrial fibrillation, anticoagulation, and stroke. , 1996, American Journal of Cardiology.

[23]  Harris Mi,et al.  Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired glucose tolerance in adults 20-74 years of age. , 1987 .

[24]  Daniel L. McGee,et al.  Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.

[25]  C. Helmers,et al.  The natural history of stroke in diabetic patients. , 2009, Acta medica Scandinavica.

[26]  R. Holman,et al.  UK Prospective Diabetes Study (UKPDS) XI: Biochemical Risk Factors in Type 2 Diabetic Patients at Diagnosis Compared with Age‐matched Normal Subjects , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[27]  S. Aronson.  INTRACRANIAL VASCULAR LESIONS IN PATIENTS WITH DIABETES MELLITUS , 1973, Journal of neuropathology and experimental neurology.

[28]  R. Holman,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[29]  M. Laakso,et al.  Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. , 1996, Stroke.

[30]  A. Heyman,et al.  I. Epidemiology For Stroke Facilities Planning , 1972 .

[31]  H. Tufo,et al.  Epidemiology of stroke in an elderly welfare population. , 1974, American journal of public health.

[32]  P. Wolf,et al.  Current status of risk factors for stroke. , 1983, Neurologic clinics.

[33]  R. Priore,et al.  Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. , 1997, Stroke.

[34]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[35]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.

[36]  A G Babiker,et al.  Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. , 1991, Statistics in medicine.

[37]  Joël Ménard,et al.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.

[38]  W. Tunbridge,et al.  FACTORS CONTRIBUTING TO DEATHS OF DIABETICS UNDER FIFTY YEARS OF AGE , 1981, The Lancet.

[39]  D. Reed,et al.  Diabetes and the risk of stroke. The Honolulu Heart Program. , 1987, JAMA.